Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system. (September 2015)
- Record Type:
- Journal Article
- Title:
- Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system. (September 2015)
- Main Title:
- Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system
- Authors:
- De Caro, Viviana
Scaturro, Anna Lisa
Di Prima, Giulia
Avellone, Giuseppe
Sutera, Flavia Maria
Di Fede, Olga
Campisi, Giuseppina
Giannola, Libero Italo - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Context</italic>: Chemoprevention of potential malignant disorders or cancerous lesions that affect oral mucosae requires extended duration of treatment. Locoregional delivery of natural products could represent a promising strategy for this purpose.</p> <p> <italic>Objective</italic>: To investigate the aptitude of aloin to permeate through, or accumulate in, the buccal mucosa and to develop a new prolonged oro-mucosal drug delivery system.</p> <p> <italic>Materials and methods</italic>: Permeation/accumulation of aloin from Curacao Aloe (containing 50% barbaloin) was evaluated <italic>ex vivo</italic>, using porcine buccal mucosa as the most useful model to simulate human epithelium. Oro-mucosal matrix tablets were prepared by dispersing aloin (10% w/w) in Eudragit® RS 100 as, biocompatible, low permeable, pH-independent, and non-swelling polymer. The prepared tablets were evaluated for drug–polymer compatibility, weight variation, drug uniformity content, diameter, thickness, hardness, friability, swelling, mucoadhesive strength, and drug release.</p> <p> <italic>Results</italic>: Aloin has low tendency to cross buccal mucosa, permeation is marginal, and high drug amounts remain entrapped into the epithelium. Matrix tablets characteristics were in agreement with pharmacopoeial requirements. Drug release showed highly reproducible Higuchian profile. Delivery through matrix tablets promoted drug accumulation in the mucosal<abstract> <title>Abstract</title> <p> <italic>Context</italic>: Chemoprevention of potential malignant disorders or cancerous lesions that affect oral mucosae requires extended duration of treatment. Locoregional delivery of natural products could represent a promising strategy for this purpose.</p> <p> <italic>Objective</italic>: To investigate the aptitude of aloin to permeate through, or accumulate in, the buccal mucosa and to develop a new prolonged oro-mucosal drug delivery system.</p> <p> <italic>Materials and methods</italic>: Permeation/accumulation of aloin from Curacao Aloe (containing 50% barbaloin) was evaluated <italic>ex vivo</italic>, using porcine buccal mucosa as the most useful model to simulate human epithelium. Oro-mucosal matrix tablets were prepared by dispersing aloin (10% w/w) in Eudragit® RS 100 as, biocompatible, low permeable, pH-independent, and non-swelling polymer. The prepared tablets were evaluated for drug–polymer compatibility, weight variation, drug uniformity content, diameter, thickness, hardness, friability, swelling, mucoadhesive strength, and drug release.</p> <p> <italic>Results</italic>: Aloin has low tendency to cross buccal mucosa, permeation is marginal, and high drug amounts remain entrapped into the epithelium. Matrix tablets characteristics were in agreement with pharmacopoeial requirements. Drug release showed highly reproducible Higuchian profile. Delivery through matrix tablets promoted drug accumulation in the mucosal tissue.</p> <p> <italic>Discussion and conclusion</italic>: Following application of matrix tablets on porcine buccal mucosa, the amount of discharged drug recovered in the tissue should be sufficient to produce the desired effects, providing therapeutic drug levels directly at the site of action. Aloin-loaded tablets are valid candidates for prevention/treatment of potentially malignant disorders and oral cancer and could potentially lead to clinically relevant drug delivery system as coadjuvant of conventional chemotherapy/radiation therapy.</p> </abstract> … (more)
- Is Part Of:
- Drug development and industrial pharmacy. Volume 41:Number 9(2015:Sep.)
- Journal:
- Drug development and industrial pharmacy
- Issue:
- Volume 41:Number 9(2015:Sep.)
- Issue Display:
- Volume 41, Issue 9 (2015)
- Year:
- 2015
- Volume:
- 41
- Issue:
- 9
- Issue Sort Value:
- 2015-0041-0009-0000
- Page Start:
- 1541
- Page End:
- 1547
- Publication Date:
- 2015-09
- Subjects:
- Pharmaceutical chemistry -- Periodicals
Pharmaceutical industry -- Periodicals
Drug Industry -- Periodicals
Technology, Pharmaceutical -- Periodicals
615.05 - Journal URLs:
- http://informahealthcare.com/loi/ddi ↗
http://informahealthcare.com ↗ - DOI:
- ↗
- Languages:
- English
- ISSNs:
- 0363-9045
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.116000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2965.xml